Not applicableStudy completedNCT03663647What this trial is testingAdvanced Melanoma in Russian ExperienceWho this might be right forCutaneous Melanoma, Stage IVBRAF V600 Mutation MelanomaPRO, Russia 382
Testing effectiveness (Phase 2)Study completedNCT04187833What this trial is testingNivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness GenesWho this might be right forMetastatic or Unresectable Melanoma Case Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00313235What this trial is testingCombined Modality Treatment for Patients With Stage IV MelanomaWho this might be right forMalignant Melanoma Stage IV Baylor Research Institute 41
Testing effectiveness (Phase 2)Looking for participantsNCT05588453What this trial is testingNatural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the BrainWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the BrainMetastatic Melanoma+1 more Kari Kendra 24
Not applicableEnded earlyNCT04577729What this trial is testingThe IRMI-FMT TrialWho this might be right forFecal Microbiota TransplantationMalignant Melanoma Stage IIIMalignant Melanoma Stage IV Medical University of Graz 5
Not applicableLooking for participantsNCT05878977What this trial is testingBiomarkers in Immunotherapy of MelanomaWho this might be right forMetastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more Institute of Oncology Ljubljana 150
Testing effectiveness (Phase 2)WithdrawnNCT01340729What this trial is testingOpen-Label Study of TPI 287 for Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00121225What this trial is testingVorinostat in Treating Patients With Metastatic or Unresectable MelanomaWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeExtraocular Extension MelanomaIris Melanoma+4 more National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07651618What this trial is testingA Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic MelanomaWho this might be right forMelanoma (Skin Cancer)Melanoma Metastatic East Metropolitan Health Service, Australia 10
Testing effectiveness (Phase 2)Study completedNCT00019890What this trial is testingVaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic MelanomaWho this might be right forStage IV MelanomaStage III MelanomaRecurrent Melanoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00910650What this trial is testingStudy of Gene Modified Immune Cells in Patients With Advanced MelanomaWho this might be right forMetastatic Melanoma Jonsson Comprehensive Cancer Center 14
Not applicableLooking for participantsNCT07112170What this trial is testingConsolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic MelanomaWho this might be right forMetastatic MelanomaOligoProgressive Metastatic Disease University Health Network, Toronto 52
Testing effectiveness (Phase 2)Study completedNCT01266967What this trial is testingGSK2118436 in BRAF Mutant Metastatic Melanoma to the BrainWho this might be right forMelanoma and Brain Metastases GlaxoSmithKline 172
Testing effectiveness (Phase 2)Study completedNCT00984464What this trial is testingStudy of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma Oncolytics Biotech 14
Not applicableStudy completedNCT02663232What this trial is testingStudy to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic MelanomaWho this might be right forMetastatic Cancers Hoffmann-La Roche 264
Testing effectiveness (Phase 2)Active Not RecruitingNCT04645680What this trial is testingDiet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving ImmunotherapyWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+7 more M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00019214What this trial is testingVaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01460134What this trial is testingCDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic CancersWho this might be right forCD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more Celldex Therapeutics 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03175432What this trial is testingBevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain MetastasesWho this might be right forBRAF V600 Wild TypeClinical Stage IV Cutaneous Melanoma AJCC v8Intracranial Melanoma+4 more M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT01681212What this trial is testingPhase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 21